{
  "id": 368097,
  "title": "Pharma giant Teva seeks to hide Israel ties from jury in price-fixing trial",
  "url": "https://urgent.news/2026/08/09/pharma-giant-teva-seeks-to-hide-israel-ties-from-jury-in-price-fixing",
  "topic": "business",
  "section": "Business",
  "published": "2026-08-09T09:16:19.000Z",
  "source": {
    "name": "Haaretz",
    "slug": "haaretz",
    "url": "https://www.haaretz.com/israel-news/business/economy-finance/2026-08-09/ty-article/pharma-giant-teva-seeks-to-hide-israel-ties-from-jury-in-price-fixing-trial/0000019f-e55f-dfd7-a19f-e7dfb4590000"
  },
  "original_language": "en",
  "account": "Israeli pharmaceutical giant Teva has requested a U.S. judge to exclude insurer Humana from informing jurors of Teva's Israeli roots during a significant drug price-fixing trial, citing concerns that public sentiment regarding the Gaza conflict could influence the proceedings and jeopardize Teva's fair trial. In a recent court filing, Teva, headquartered in Tel Aviv, argued that its national origin is irrelevant to the central claim of the lawsuit - the alleged conspiracy to inflate prices of generic drugs. The trial, tentatively set to commence on September 15 and conclude by late October, will feature multiple drug manufacturers among the defendants. This move highlights the heightened tensions surrounding the Gaza war that have permeated American society, potentially impacting cases involving Israeli entities. Teva's legal team emphasized the irrelevance of its corporate origins to the case and argued that mentioning its Israeli parent company could be prejudicial to the jury. Humana, the insurer facing Teva in the lawsuit, declined to comment on the matter. Teva has refuted Humana's accusations of collusion in setting drug prices for products like baclofen and propranolol. The company maintains its U.S.-based subsidiary is the defendant in the case. Multiple companies often request judges to restrict the evidence jurors can consider, arguing that certain information may unduly influence their verdict. Teva referenced a recent poll indicating that 60% of Americans hold a negative view of Israel, citing protests at U.S. colleges and acts of violence against those perceived as affiliated with the country. Humana, in its filing, sought to bar Teva and other drug companies from presenting \"inflammatory arguments or evidence\" about health insurance practices broadly, including cases of denied claims.",
  "summary": "The company argued that strong public views over the Gaza war could prejudice proceedings and affect its ability to receive a fair hearing. The filing underscored how tensions over the war in Gaza have become in the U.S.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}